High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2014, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2014-02-25
DOI
10.1155/2014/509027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune-suppressive properties of the tumor microenvironment
- (2013) Jürgen C. Becker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Expression of p53 in imprint smears of endometrial carcinoma
- (2013) Kosmas Konstantinos et al. DIAGNOSTIC CYTOPATHOLOGY
- Anti-CD73 therapy impairs tumor angiogenesis
- (2013) Bertrand Allard et al. INTERNATIONAL JOURNAL OF CANCER
- Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states
- (2013) Maria Serena Longhi et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Reduced striatal ecto-nucleotidase activity in schizophrenia patients supports the “adenosine hypothesis”
- (2013) Elisabet Aliagas et al. Purinergic Signalling
- Purines, Purinergic Receptors, and Cancer
- (2012) F. Di Virgilio CANCER RESEARCH
- High-grade endometrial carcinomas - strategies for typing
- (2012) Robert A Soslow HISTOPATHOLOGY
- Molecular pathology of endometrial carcinoma
- (2012) Xavier Matias-Guiu et al. HISTOPATHOLOGY
- Opportunities and challenges for anti-CD73 cancer therapy
- (2012) Bin Zhang Immunotherapy
- Production of Adenosine by Ectonucleotidases: A Key Factor in Tumor Immunoescape
- (2012) François Ghiringhelli et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Inhibition of CD73 Improves B Cell-Mediated Anti-Tumor Immunity in a Mouse Model of Melanoma
- (2012) G. Forte et al. JOURNAL OF IMMUNOLOGY
- ENTPD1/CD39 is a promising therapeutic target in oncology
- (2012) J Bastid et al. ONCOGENE
- Ecto-nucleotidases distribution in human cyclic and postmenopausic endometrium
- (2012) Elisabet Aliagas et al. Purinergic Signalling
- Cellular function and molecular structure of ecto-nucleotidases
- (2012) Herbert Zimmermann et al. Purinergic Signalling
- Molecular markers of endometrial carcinoma detected in uterine aspirates
- (2011) Eva Colas et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
- (2011) Beat M. Künzli et al. Purinergic Signalling
- Changes in expression and activity levels of ecto-5′-nucleotidase/CD73 along the mouse female estrous cycle
- (2010) E. Aliagas et al. Acta Physiologica
- Extracellular adenosine triphosphate and adenosine in cancer
- (2010) J Stagg et al. ONCOGENE
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
- (2010) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential ectonucleotidase expression in human bladder cancer cell lines
- (2009) Joséli Stella et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade
- (2008) Gennady G. Yegutkin BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Central role of Sp1-regulated CD39 in hypoxia/ischemia protection
- (2008) H. K. Eltzschig et al. BLOOD
- Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia
- (2008) M. V. Sitkovsky et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started